{"id":2819,"date":"2019-02-07T16:09:25","date_gmt":"2019-02-07T15:09:25","guid":{"rendered":"https:\/\/triton.u707.jussieu.fr\/hepatherWPpreprod\/?page_id=2819"},"modified":"2019-07-04T14:25:46","modified_gmt":"2019-07-04T12:25:46","slug":"projets-valides-par-le-cs","status":"publish","type":"page","link":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/","title":{"rendered":"Projets valid\u00e9s par le CS"},"content":{"rendered":"
\n
\n
\n
\n

Projets en cours<\/h3>\n
\n

Stratification of Hepatocellular carcinoma risk using Biomarkers (STHEPBIO): Genome-based HCC-risk assessment models and sequential serum biomarkers for prediction and early detection of liver cancer<\/strong>
\nCoordonnateur : Pierre Nahon
\nN\u00b0 de CS de soumission : 20
\nDate CS : 12\/12\/2018<\/p>\n

Epid\u00e9miologie clinique des lymphomes associ\u00e9s \u00e0 une h\u00e9patite B chronique
\n<\/strong>Coordonnateur : Caroline Besson
\nN\u00b0 de CS de soumission : 16
\nDate CS : 14\/06\/2017<\/p>\n

Quantification des diff\u00e9rentes formes circulantes \u00e0 ARN (\u00e9piss\u00e9es ou non) du Virus de l\u2019h\u00e9patite B au cours de l\u2019infection et du traitement antiviral<\/strong>
\nCoordonnateur : Patrick Soussan
\nN\u00b0 de CS de soumission : 15
\nDate CS : 01\/03\/2017<\/p>\n

Host factors in hepatitis B virus cccDNA formation as novel antiviral targets and biomarkers \u2013 identification, preclinical evaluation and impact for liver disease<\/strong>
\nCoordonnateur : Thomas Baumert
\nN\u00b0 de CS de soumission : 15
\nDate CS : 01\/03\/2017<\/p>\n

Validation prospective des facteurs de risque et scores pr\u00e9dictifs de CHC chez des patients occidentaux atteints d\u2019h\u00e9patite chronique virale B et C<\/strong>
\nCoordonnateur : Nathalie Ganne-Carrie
\nN\u00b0 de CS de soumission : 11
\nDate CS : 16\/03\/2016<\/p>\n

Identification des variants g\u00e9n\u00e9tiques impliqu\u00e9s dans les lymphomes B non Hodgkiniens li\u00e9s au virus de l\u2019H\u00e9patite C<\/strong>
\nCoordinateurs : Olivier Hermine et Caroline Besson
\nN\u00b0 de CS de soumission : 8
\nDate CS : 10\/06\/2015<\/p>\n

Comparaison de la r\u00e9ponse au traitement antiviral \u00e0 action directe (AAD) entre les patients co-infect\u00e9s (ANRS CO13 HEPAVIH) par le VIH\/VHC et les patients mono-infect\u00e9s (ANRS CO22 HEPATHER)<\/strong>
\nCoordonnateur : Linda Wittkop
\nN\u00b0 de CS de soumission : 8
\nDate CS : 10\/06\/2015<\/p>\n

Evaluation de l\u2019impact des antiviraux directs sur l\u2019\u00e9volution des lymphomes non Hodgkiniens associ\u00e9s au virus de l\u2019h\u00e9patite C
\n<\/strong>Coordonnateur : Olivier Hermine et Caroline Besson
\nN\u00b0 de CS de soumission : NA
\nDate CS : 11\/03\/2015<\/p>\n

Optimisation et validation d\u2019un test g\u00e9n\u00e9tique de pr\u00e9diction des cirrhoses<\/strong>
\nCoordonnateur : Alain Dessein
\nN\u00b0 de CS de soumission : 7
\nDate CS : 11\/03\/2015<\/p>\n

Etude des caract\u00e9ristiques \u00e9pid\u00e9miologiques, radiologiques et histologiques d\u2019une tumeur primitive du foie carcinome hepatocellulaire ou cholangiocarcinome chez des patients \u00e9radiqu\u00e9s du virus de l\u2019h\u00e9patite C et chez des patients contr\u00f4l\u00e9s pour le virus de l\u2019h\u00e9patite B<\/strong>
\nCoordonnateur : Jean-Charles Duclos-Vall\u00e9e et Pierre Nahon
\nN\u00b0 de CS de soumission : 5
\nDate CS : 10\/09\/2014<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n

Projets finalis\u00e9s<\/h3>\n
\n

Observatoire national de la r\u00e9sistance du virus de l\u2019h\u00e9patite C aux antiviraux directs (DAA)<\/strong>
\nCoordinateurs : St\u00e9phane Chevaliez et Jean-Michel Pawlotsky
\nN\u00b0 de CS de soumission : NA
\nDate CS : 11\/03\/2015<\/p>\n

Vascularites cryoglobulin\u00e9miques li\u00e9es au virus de l\u2019h\u00e9patite C trait\u00e9es par les agents antiviraux directs<\/strong>
\nCoordonnateur : Patrice Cacoub
\nN\u00b0 de CS de soumission : 7 Date
\nCS : 11\/03\/2015<\/p>\n

Evolution des caract\u00e9ristiques \u00e9pid\u00e9miologiques des personnes prises en charge pour une h\u00e9patite C en France, entre 2001-2007 et 2012-2015 dans les services d\u2019h\u00e9pato-gastroent\u00e9rologie (surveillance nationale de l\u2019h\u00e9patite C 2000-2007, ANRS CO22 HEPATHER 2012-2015)
\n<\/strong>Coordonnateur : Christine Larsen
\nN\u00b0 de CS de soumission : 6
\nDate CS : 10\/12\/2014<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n

Projets non d\u00e9but\u00e9s<\/h3>\n
\n

Liver stiffness measurement in HCV patients treated with DAA. A long-term prognosis study. VERTIGO Study<\/strong>
\nCoordonnateur : Victor De Ledinghen
\nN\u00b0 de CS de soumission : 16
\nDate CS : 14\/06\/2017<\/p>\n

HEPATOMIC : a transcriptome analysis to identify the biomarkers associated HBV functional cure<\/strong>
\nCoordonnateurs : Massimo Levrero et Fabien Zoulim
\nN\u00b0 de CS de soumission : 11
\nDate CS : 16\/03\/2016<\/p>\n

Etude de la cardiotoxicit\u00e9 potentielle des anti-viraux directs utilis\u00e9s au cours du traitement anti-viral C<\/strong>
\nCoordonnateur : H\u00e9l\u00e8ne Fontaine
\nN\u00b0 de CS de soumission : 8
\nDate CS : 10\/06\/2015<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n

Projets abandonn\u00e9s<\/h3>\n
\n

HBV Immunscreen \u2013 applying concepts of immune response variability for the identification of HBV patients that will benefit from combination immunotherapy studies<\/strong>
\nCoordonnateur : Stanislas Pol
\nN\u00b0 de CS de soumission : 11
\nDate CS : 16\/03\/2016<\/p>\n

Les marqueurs virologiques novateurs du VHB : une comparaison entre les patients mono-infect\u00e9s VHB et co-infect\u00e9s VIH-VHB trait\u00e9s au long cours par tenofovir<\/strong>
\nCoordonnateur : Anders Boyd
\nN\u00b0 de CS de soumission : 14
\nDate CS : 07\/12\/2016<\/p>\n

ETNA : ETude de la pharmacovigilance des Nouveaux Agents antiviraux directs : estimation de l\u2019association entre l\u2019exposition au traitement par AAD et la survenue, la r\u00e9cidive ou l\u2019\u00e9volution PRECOCES d\u2019un carcinome h\u00e9patocellulaire<\/strong>
\nCoordonnateur : Claire Jezequel
\nN\u00b0 de CS de soumission : 9
\nDate CS : 23\/09\/2015<\/p>\n

Understanding differences in HBV genetic variability and host immunological deficiencies among HIV-HBV infected patients exhibiting persistent viremia during long-term treatment with tenofovir<\/strong>
\nCoordonnateurs : Anders Boyd et Karine Lacombe
\nN\u00b0 de CS de soumission : 9
\nDate CS : 23\/09\/2015<\/p>\n

Etude pharmacocin\u00e9tique (PK) et pharmacocin\u00e9tique\/pharmacodynamique (PK\/PD) des nouveaux antiviraux anti-VHC directs (AAD) chez des patients mono- et co-infect\u00e9s VIH-VHC cirrhotiques rechuteurs ou non r\u00e9pondeurs ant\u00e9rieurs<\/strong>
\nCoordonnateur : Gilles Peytavin
\nN\u00b0 de CS de soumission : 5 Date
\nCS : 10\/09\/2014<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Projets en cours Stratification of Hepatocellular carcinoma risk using Biomarkers (STHEPBIO): Genome-based HCC-risk assessment models and sequential serum biomarkers for prediction and early detection of liver cancer Coordonnateur : Pierre Nahon N\u00b0 de CS de soumission : 20 Date CS : 12\/12\/2018 Epid\u00e9miologie clinique des lymphomes associ\u00e9s \u00e0 une h\u00e9patite B chronique Coordonnateur : Caroline […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-2819","page","type-page","status-publish","hentry"],"yoast_head":"\nProjets valid\u00e9s par le CS - ANRS CO22 HEPATHER<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Projets valid\u00e9s par le CS - ANRS CO22 HEPATHER\" \/>\n<meta property=\"og:description\" content=\"Projets en cours Stratification of Hepatocellular carcinoma risk using Biomarkers (STHEPBIO): Genome-based HCC-risk assessment models and sequential serum biomarkers for prediction and early detection of liver cancer Coordonnateur : Pierre Nahon N\u00b0 de CS de soumission : 20 Date CS : 12\/12\/2018 Epid\u00e9miologie clinique des lymphomes associ\u00e9s \u00e0 une h\u00e9patite B chronique Coordonnateur : Caroline […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/\" \/>\n<meta property=\"og:site_name\" content=\"ANRS CO22 HEPATHER\" \/>\n<meta property=\"article:modified_time\" content=\"2019-07-04T12:25:46+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/\",\"name\":\"Projets valid\u00e9s par le CS - ANRS CO22 HEPATHER\",\"isPartOf\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website\"},\"datePublished\":\"2019-02-07T15:09:25+00:00\",\"dateModified\":\"2019-07-04T12:25:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projets valid\u00e9s par le CS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\",\"name\":\"ANRS CO22 HEPATHER\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization\",\"name\":\"IPLESP UMRS 1136\",\"url\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1\",\"width\":464,\"height\":175,\"caption\":\"IPLESP UMRS 1136\"},\"image\":{\"@id\":\"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Projets valid\u00e9s par le CS - ANRS CO22 HEPATHER","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/","og_locale":"fr_FR","og_type":"article","og_title":"Projets valid\u00e9s par le CS - ANRS CO22 HEPATHER","og_description":"Projets en cours Stratification of Hepatocellular carcinoma risk using Biomarkers (STHEPBIO): Genome-based HCC-risk assessment models and sequential serum biomarkers for prediction and early detection of liver cancer Coordonnateur : Pierre Nahon N\u00b0 de CS de soumission : 20 Date CS : 12\/12\/2018 Epid\u00e9miologie clinique des lymphomes associ\u00e9s \u00e0 une h\u00e9patite B chronique Coordonnateur : Caroline […]","og_url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/","og_site_name":"ANRS CO22 HEPATHER","article_modified_time":"2019-07-04T12:25:46+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/","name":"Projets valid\u00e9s par le CS - ANRS CO22 HEPATHER","isPartOf":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website"},"datePublished":"2019-02-07T15:09:25+00:00","dateModified":"2019-07-04T12:25:46+00:00","breadcrumb":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/projets-valides-par-le-cs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/"},{"@type":"ListItem","position":2,"name":"Projets valid\u00e9s par le CS"}]},{"@type":"WebSite","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#website","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/","name":"ANRS CO22 HEPATHER","description":"","publisher":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#organization","name":"IPLESP UMRS 1136","url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1","contentUrl":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/02\/logoTagline_anrs_white.png?fit=464%2C175&ssl=1","width":464,"height":175,"caption":"IPLESP UMRS 1136"},"image":{"@id":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/PaQKc4-Jt","jetpack-related-posts":[{"id":36,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/contact-et-plan\/","url_meta":{"origin":2819,"position":0},"title":"Contact et plan","author":"admin_fchau","date":"11 d\u00e9cembre 2017","format":false,"excerpt":"Institut Pierre-Louis Epid\u00e9miologie et Sant\u00e9 Publique Unit\u00e9 Mixte de Recherche en Sant\u00e9 n\u00b01136 T\u00e9l\u00e9phone : +33 (0) 142 164 260 & +33 (0) 142 164 272 - Fax +33 (0) 142 164 261 Adresse: 56, boulevard Vincent Auriol - CS 81393 - 75646 Paris Cedex 13 - France \u00a0","rel":"","context":"Article similaire","block_context":{"text":"Article similaire","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":188,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/espace-patients\/les-etudes-en-cours\/","url_meta":{"origin":2819,"position":1},"title":"Les \u00e9tudes valid\u00e9es par le Conseil scientifique","author":"admin_fchau","date":"24 janvier 2018","format":false,"excerpt":"\/ A MODIFIER \/ Liste des PRS acad\u00e9miques valid\u00e9s : Etude de la qualit\u00e9 de vie des patients affect\u00e9s d'une h\u00e9patite C chronique suivis en\u00a0 consultation hospitali\u00e8re Coordonnateur : Yazdan Yazdanpanah Date de validation : Observatoire national de la r\u00e9sistance du virus de l'h\u00e9patite C aux antiviraux directs (DAA) Les\u2026","rel":"","context":"Article similaire","block_context":{"text":"Article similaire","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/triton.u707.jussieu.fr\/hepatherWPpreprod\/wp-content\/uploads\/2019\/01\/pictos_avancement_etude-1-e1546595305448.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":205,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/espace-chercheur\/publications\/","url_meta":{"origin":2819,"position":2},"title":"Publications","author":"admin_fchau","date":"24 janvier 2018","format":false,"excerpt":"2021 Late presentation for HCV care: time to target people with diabetes and\/or hazardous alcohol use (ANRS CO22 HEPATHER cohort). Santos M, Protopescu C, Delarocque-Astagneau E, Bourli\u00e8re M, Petrov-Sanchez V, Di Beo V, Larrey D, Baudoin M, Dorival C, Bureau M, Fontaine H, Carrat F, Marcellin F, Pol S, Carrieri\u2026","rel":"","context":"Article similaire","block_context":{"text":"Article similaire","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1016,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/la-cohorte\/description-de-la-cohorte\/equipes-impliquees\/","url_meta":{"origin":2819,"position":3},"title":"Les \u00e9quipes impliqu\u00e9es","author":"admin_ft","date":"23 octobre 2018","format":false,"excerpt":"Investigateur coordonnateur : Pr Stanislas POL, Unit\u00e9 d\u2019H\u00e9patologie M\u00e9dicale, H\u00f4pital Cochin Saint-Vincent de Paul, 75014 Paris Co-investigateur coordonnateur : Dr H\u00e9l\u00e8ne FONTAINE, Unit\u00e9 d\u2019H\u00e9patologie M\u00e9dicale, H\u00f4pital Cochin Saint-Vincent de Paul, 75014 Paris Responsable scientifique et responsable du Centre de M\u00e9thodologie et de Gestion : Pr Fabrice CARRAT, UMR-S 1136, H\u00f4pital\u2026","rel":"","context":"Article similaire","block_context":{"text":"Article similaire","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2019\/06\/logo_iplesp_couleurs-1-300x139.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":1477,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/la-cohorte\/description-de-la-cohorte\/biobanque\/","url_meta":{"origin":2819,"position":4},"title":"Biobanque","author":"admin_ft","date":"30 octobre 2018","format":false,"excerpt":"Une biobanque est r\u00e9alis\u00e9e chez tous les patients inclus au moment de la visite d'inclusion. Il n'y a pas de pr\u00e9l\u00e8vements centralis\u00e9s et mis en biobanque pendant le suivi du patient. Cependant, dans certains cas de projets sp\u00e9cifiques et avec les accords r\u00e9glementaires n\u00e9cessaires, une biobanque de suivi peut \u00eatre\u2026","rel":"","context":"Article similaire","block_context":{"text":"Article similaire","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-content\/uploads\/2022\/03\/visite_inclusion-360x239-1.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":203,"url":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/espace-chercheur\/deposer-un-projet\/","url_meta":{"origin":2819,"position":5},"title":"D\u00e9poser un projet","author":"admin_fchau","date":"24 janvier 2018","format":false,"excerpt":"D\u00e9marches \u00e0 suivre pour le d\u00e9p\u00f4t de projets acad\u00e9miques : La cohorte ANRS CO22 HEPATHER est une plateforme de recherche ouverte \u00e0 la communaut\u00e9. Tout chercheur peut proposer un projet nich\u00e9 sur des patients inclus dans la cohorte. La 1\u00e8re \u00e9tape consiste \u00e0 compl\u00e9ter et soumettre le formulaire de soumission\u2026","rel":"","context":"Article similaire","block_context":{"text":"Article similaire","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/pages\/2819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/comments?post=2819"}],"version-history":[{"count":6,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/pages\/2819\/revisions"}],"predecessor-version":[{"id":3171,"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/pages\/2819\/revisions\/3171"}],"wp:attachment":[{"href":"https:\/\/triton.iplesp.upmc.fr\/hepather_ANRS\/wp-json\/wp\/v2\/media?parent=2819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}